The American College of Toxicology's annual meeting aims to update attendees on emerging trends in the discipline of toxicology. This year’s meeting will include a diverse scientific programme and a traditional poster reception session for attendees and exhibitors.
Dr Helen Prior will be presenting work on “When would data from a single species be sufficient for safe progression in humans” in Symposium 10: Integration of consortia recommendations for justification of animal use within current and future drug development paradigms’ on Tuesday 6 November 9-12am. Prof Ian Kimber is a co-chair of this session, which was proposed and organised by the NC3Rs to bring together scientists and regulators from four separate industry consortia (IQ-DruSafe, EFPIA, Biosafe and NC3Rs).
Two further posters with results from the NC3Rs/ABPI working group project ‘Review of the use of a second species in regulatory studies’ will be presented, entitled ‘Can we expand the use of one species for post-‘First-in-Human’ (FIH) studies, within and beyond ICHS6?’ and ‘Trends toward a reduction in the use of recovery animals for First-In-Human (FIH) studies from 2013 to 2017.’
We will also have a stand within the exhibition hall (booth number 503).
For more information, visit the ACT 2018 website.